Cargando…

Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the Prognosis

Transcription factor Growth Factor Independence 1 (GFI1) regulates the expression of genes important for survival, proliferation and differentiation of hematopoietic cells. A single nucleotide polymorphism (SNP) variant of GFI1 (GFI1-36N: serine replaced by asparagine at position 36), has a prevalen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khandanpour, Cyrus, Eisfeld, Christine, Nimmagadda, Subbaiah Chary, Raab, Marc S., Weinhold, Niels, Seckinger, Anja, Hose, Dirk, Jauch, Anna, Försti, Asta, Hemminki, Kari, Hielscher, Thomas, Hummel, Manuela, Lenz, Georg, Goldschmidt, Hartmut, Huhn, Stefanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574071/ https://www.ncbi.nlm.nih.gov/pubmed/34760702 http://dx.doi.org/10.3389/fonc.2021.757664

Ejemplares similares

GFI1B acts as a metabolic regulator in hematopoiesis and acute myeloid leukemia
por: Liu, Longlong, et al.
Publicado: (2022)

Gfi1 as a regulator of p53 and a therapeutic target for ALL
por: Khandanpour, Cyrus, et al.
Publicado: (2013)

Role of GFI1 in Epigenetic Regulation of MDS and AML Pathogenesis: Mechanisms and Therapeutic Implications
por: Möröy, Tarik, et al.
Publicado: (2019)

GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome
por: Botezatu, Lacramioara, et al.
Publicado: (2016)

Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition
por: Vorwerk, Jan, et al.
Publicado: (2022)

P1005: EFFECT OF TL-895, A NOVEL BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ON ONCOGENIC JANUS KINASE 2-V617F (JAK2VF) SIGNALING
por: Chary Nimmagadda, Subbaiah, et al.
Publicado: (2023)

High Metabolic Dependence on Oxidative Phosphorylation Drives Sensitivity to Metformin Treatment in MLL/AF9 Acute Myeloid Leukemia
por: Liu, Longlong, et al.
Publicado: (2022)

Reduced expression but not deficiency of GFI1 causes a fatal myeloproliferative disease in mice
por: Fraszczak, Jennifer, et al.
Publicado: (2018)

Dose-dependent effect of GFI1 expression in the reconstitution and the differentiation capacity of HSCs
por: Xie, Xiaoqing, et al.
Publicado: (2023)

Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells
por: Meißner, Tobias, et al.
Publicado: (2015)

Threshold Levels of Gfi1 Maintain E2A Activity for B Cell Commitment via Repression of Id1
por: Fraszczak, Jennifer, et al.
Publicado: (2016)

Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial
por: Hose, Dirk, et al.
Publicado: (2019)

Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis
por: Granzow, Martin, et al.
Publicado: (2017)

Inhibiting PI3K–AKT–mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells
por: Heinemann, Luca, et al.
Publicado: (2022)

Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS)
por: Xie, Xiaoqing, et al.
Publicado: (2021)

Allelotyping of pooled DNA with 250 K SNP microarrays
por: Wilkening, Stefan, et al.
Publicado: (2007)

Enforced GFI1 expression impedes human and murine leukemic cell growth
por: Hönes, Judith M., et al.
Publicado: (2017)

Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
por: Liu, Longlong, et al.
Publicado: (2022)

Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma
por: Niazi, Yasmeen, et al.
Publicado: (2022)

Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma
por: Mai, Elias K., et al.
Publicado: (2023)

Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies
por: Schütte, Judith, et al.
Publicado: (2019)

The Glycome of Normal and Malignant Plasma Cells
por: Moehler, Thomas M., et al.
Publicado: (2013)

Direct transcriptional repression of the genes encoding the zinc-finger proteins Gfi1b and Gfi1 by Gfi1b
por: Vassen, Lothar, et al.
Publicado: (2005)

GFI1 facilitates efficient DNA repair by regulating PRMT1 dependent methylation of MRE11 and 53BP1
por: Vadnais, Charles, et al.
Publicado: (2018)

CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma
por: Alaterre, Elina, et al.
Publicado: (2017)

Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation
por: Merz, Maximilian, et al.
Publicado: (2017)

Gfi1b: a key player in the genesis and maintenance of acute myeloid leukemia and myelodysplastic syndrome
por: Thivakaran, Aniththa, et al.
Publicado: (2018)

The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
por: Hemminki, Kari, et al.
Publicado: (2016)

Survival in colon and rectal cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2021)

Gfi1 and Gfi1b Repress Rag Transcription in Plasmacytoid Dendritic Cells In Vitro
por: Chow, Kwan T., et al.
Publicado: (2013)

Incidence, Mortality and Survival Trends in Breast Cancers Coincident with Introduction of Mammography in the Nordic Countries
por: Hemminki, Kari, et al.
Publicado: (2022)

RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma
por: Emde-Rajaratnam, Martina, et al.
Publicado: (2023)

Genome-wide interaction and pathway-based identification of key regulators in multiple myeloma
por: Chattopadhyay, Subhayan, et al.
Publicado: (2019)

Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment
por: Hemminki, Kari, et al.
Publicado: (2022)

Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century
por: Koskinen, Anni, et al.
Publicado: (2022)

Survival trends in hematological malignancies in the Nordic countries through 50 years
por: Hemminki, Kari, et al.
Publicado: (2022)

Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment
por: Hemminki, Kari, et al.
Publicado: (2023)

Conditional survival in breast cancer up to 10 years in the Nordic countries
por: Zitricky, Frantisek, et al.
Publicado: (2023)

Multifaceted Actions of GFI1 and GFI1B in Hematopoietic Stem Cell Self-Renewal and Lineage Commitment
por: Beauchemin, Hugues, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lcnuf83ju5dap7f96lrdho6jpo